Literature DB >> 10770475

Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression.

C DeBattista, H B Solvason, J A Breen, A F Schatzberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770475     DOI: 10.1097/00004714-200004000-00029

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  6 in total

Review 1.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03

Review 2.  Defining biotypes for depression and anxiety based on large-scale circuit dysfunction: a theoretical review of the evidence and future directions for clinical translation.

Authors:  Leanne M Williams
Journal:  Depress Anxiety       Date:  2016-09-21       Impact factor: 6.505

3.  The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.

Authors:  Judith A Siuciak; Remie A Fujiwara
Journal:  Psychopharmacology (Berl)       Date:  2004-02-25       Impact factor: 4.530

4.  Binding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457.

Authors:  Kenji Ishibashi; Kenji Ishii; Keiichi Oda; Hidehiro Mizusawa; Kiichi Ishiwata
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

Review 5.  Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.

Authors:  Mostafa El Mansari; Bruno P Guiard; Olga Chernoloz; Ramez Ghanbari; Noam Katz; Pierre Blier
Journal:  CNS Neurosci Ther       Date:  2010-04-08       Impact factor: 5.243

6.  Novel anti-inflammatory and analgesic agents: synthesis, molecular docking and in vivo studies.

Authors:  David Izuchukwu Ugwu; Uchechukwu Christopher Okoro; Pius Onyeoziri Ukoha; Astha Gupta; Sunday N Okafor
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.